Pliant Therapeutics
CA - South SFBiotechnology
Focus: Pliant Therapeutics is a pre-revenue biotech focused on anti-fibrotic treatments for respiratory and oncology indications. The company operates from South San Francisco with a lean, specialized team targeting underserved fibrotic disease markets.
Profile data last refreshed 19h ago · AI intelligence enriched 2w ago
Open Jobs
3
Should You Work at Pliant Therapeutics?
AI assessmentPliant is a high-risk, high-reward early-stage bet suitable only for career scientists seeking equity upside and deep technical involvement in fibrosis biology, not stability.
Why Work Here
- Early-stage opportunity in high-unmet-need fibrotic disease space with PLN-74809 in Phase 2 across multiple indications (IPF, ARDS, PSC)
- South SF location provides access to Bay Area biotech ecosystem and top talent pools
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
8 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
PLN-101095
Metastatic Solid TumorClinical Trials (1)
NCT06270706A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Phase 1Help build intelligence for Pliant Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.